Loading…
5 companies · GEL, thousands · columns ordered by revenue
| Line item | Georgia-Mediko | Europharma Georgia Evro… | Sap Pharma | Pharma Stori | Art Pharma |
|---|---|---|---|---|---|
| Total Revenue | 6,448 | 6,410 | 6,369 | 6,273 | 6,223 |
| Total COGS | -4,565 | -3,344 | -2,548 | -3,398 | -2,798 |
| Gross Profit | 1,883 | 3,066 | 3,822 | 2,875 | 3,425 |
| Gross Margin | 29.2% | 47.8% | 60.0% | 45.8% | 55.0% |
| Total Operating Expenses | -124 | -2,415 | -2,387 | -1,863 | -1,432 |
| EBITDA | 1,758 | 651 | 1,435 | 1,013 | 1,993 |
| EBITDA Margin | 27.3% | 10.2% | 22.5% | 16.1% | 32.0% |
| Total D&A | -19 | 0 | 0 | -28 | -42 |
| EBIT / Operating Income | 1,740 | 651 | 1,435 | 985 | 1,951 |
| Total Interest Expense | -59 | — | — | -156 | -19 |
| Profit Before Tax | 1,680 | 643 | 1,464 | 837 | 1,956 |
| Total Income Tax | 0 | 0 | 0 | -22 | 0 |
| Net Profit / (Loss) | 1,680 | 643 | 1,464 | 815 | 1,956 |
| Net Margin | 26.1% | 10.0% | 23.0% | 13.0% | 31.4% |
| Total Other Income | — | -8 | 29 | 8 | 2 |
| Total Interest Income | — | — | — | — | 22 |
| Company | Sector | EBITDA margin · FY 2024 | Percentile | Sector n |
|---|---|---|---|---|
| Art Pharma | Pharma | 32.0% | 77th pct | 110 |
| Georgia-Mediko | Pharma | 27.3% | 71st pct | 110 |
| Sap Pharma | Pharma | 22.5% | 64th pct | 110 |
| Pharma Stori | Pharma | 16.1% | 51st pct | 110 |
| Europharma Georgia Evro… | Pharma | 10.2% | 38th pct | 110 |
Percentile is within each company's own sector across the whole FY2024 cross-section (1st–100th; higher = larger value). Companies with no sector, or no filing for the year, are not ranked.